Cargando…
Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye
Background: To assess the clinical efficacy, tolerability and safety of a new-generation ophthalmic solution containing cross-linked hyaluronic acid 0.15% trehalose 3%, liposomes 1% and sterylamine 0.25% (Trimix(®) Off Health Italia, Firenze, Italy) (CXHAL) versus trehalose 3% (Thealoz(®), Thea Phar...
Autores principales: | Roszkowska, Anna Maria, Inferrera, Leandro, Spinella, Rosaria, Postorino, Elisa Imelde, Gargano, Romana, Oliverio, Giovanni Wiliam, Aragona, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740530/ https://www.ncbi.nlm.nih.gov/pubmed/36498550 http://dx.doi.org/10.3390/jcm11236975 |
Ejemplares similares
-
Safety and Tolerability of an Eye Drop Based on 0.6% Povidone–Iodine Nanoemulsion in Dry Eye Patients
por: Oliverio, Giovanni William, et al.
Publicado: (2021) -
Ophthalmologic Manifestations of Primary Sjögren’s Syndrome
por: Roszkowska, Anna Maria, et al.
Publicado: (2021) -
Impact of corneal parameters, refractive error and age on density and morphology of the subbasal nerve plexus fibers in healthy adults
por: Roszkowska, Anna M., et al.
Publicado: (2021) -
The Role of Hi-Tech Devices in Assessment of Corneal Healing in Patients with Neurotrophic Keratopathy
por: Inferrera, Leandro, et al.
Publicado: (2022) -
Neurotrophic Keratopathy in Systemic Diseases: A Case Series on Patients Treated With rh-NGF
por: Meduri, Alessandro, et al.
Publicado: (2022)